Dorsey Wright & Associates’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-637
Closed -$11K 350
2019
Q4
$11K Hold
637
﹤0.01% 236
2019
Q3
$10K Hold
637
﹤0.01% 263
2019
Q2
$12K Buy
637
+159
+33% +$2.71K ﹤0.01% 215
2019
Q1
$8K Sell
478
-474
-50% -$8.67K ﹤0.01% 235
2018
Q4
$17K Buy
+952
New +$14.2K 0.01% 165

Other funds holding VCEL

Dorsey Wright & Associates's VCEL Position: Q1 2020 in Review

Dorsey Wright & Associates sold out of Vericel Corp (VCEL) in Q1 2020, closing a stake of 637 shares — an estimated $11K sold.

Dorsey Wright & Associates first reported a position in VCEL in Q4 2018 and held it in 5 quarters. The position peaked at $17K in Q4 2018. 133 funds tracked by Wall St. Rank hold VCEL as of Q1 2020.

  • Dorsey Wright & Associates reported no remaining Vericel Corp position as of Q1 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 637 Vericel Corp shares in Q1 2020, an estimated $11K.
  • Dorsey Wright & Associates first reported a position in Vericel Corp in Q4 2018 and held it in 5 quarters.
  • Dorsey Wright & Associates's Vericel Corp position peaked at $17K in Q4 2018.
  • 133 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2020.

Based on Dorsey Wright & Associates's 13F filing for Q1 2020, filed 20 Apr 2020.